Skip to main content

Advertisement

Table 1 Adverse events observed in nine patients during the canakinumab treatment period

From: Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever

  Number (%)
Adverse events 8 (88.9)
Ankle fracture 1 (11.1)
Anxiety 1 (11.1)
Headache 4 (44.4)
Hidradenitisa 1 (11.1)
Pregnancy 1 (11.1)
Pruritus 1 (11.1)
Tooth infection 1 (11.1)
Upper respiratory tract infection 2 (22.2)
Vomiting 1 (11.1)
  1. aThis patient had a medical history of hidradenitis, and she had no serious exacerbation during canakinumab treatment